Who We Are
NellaDerm began with a personal journey.
Like many families living with eczema, we experienced the cycle of uncertainty, trial and error, temporary relief, and recurring flare-ups. It made one problem clear: inflammatory skin conditions can look similar on the surface while being shaped by very different combinations of biology, history, triggers, environment, and treatment response.
That experience shaped everything we do.
We are scientists first.
Our team brings experience in nanobiotechnology, nanomedicine, biomedical engineering, formulation science, and advanced algorithms across leading Canadian and American research institutions.
We are building NellaDerm around a simple belief: individual biological variability should be at the center of how care is understood, designed, delivered, and refined.
Care grounded in science
Our work begins with a central scientific challenge: atopic dermatitis and other inflammatory skin conditions are heterogeneous. Each individual may have a different combination of biological drivers, symptoms, triggers, body sites, history, and response to care.
That is why our research connects multidimensional Pattern Discovery, formulation science, and advanced topical delivery—and why every part of the technology is being developed together.
From research to real-world skin support
We have introduced two topical products, NovaNella and NellaCalm, informed by current scientific understanding of barrier care and irritation-prone skin.
They are designed to support the skin barrier, help soothe dryness and discomfort, and fit into consistent daily care.
These products are our first real-world foundation. They are not yet personalized and do not yet include the advanced delivery systems now under development.
They serve an important purpose:
bringing our science into practical use today while we continue building the next generation of NellaDerm technology.
MyEczema and Pattern Discovery
MyEczema.app is our free digital starting point. It helps individuals organize information such as symptoms, medical history, photos, triggers, stress, diet, environmental exposures, and treatment response. As the technology develops, this evolving care profile may also incorporate clinician notes, genetics, blood work, microbiome data, and other biological signals to support deeper Pattern Discovery—not simply a surface-level skin scan.
From patterns to personalized pathways
Pattern Discovery, using advanced algorithms to recognize meaningful relationships across biological, clinical, lifestyle, and environmental information
Formulation Pathways, using each discovered pattern to navigate our proprietary formulation library
Longitudinal Learning, refining insights over time to support more informed prevention, flare management, maintenance, and care decisions
help move dermatology from reactive, one-size-fits-all care toward more predictive, preventive, and personalized care.
Advanced topical delivery
Alongside our digital and formulation work, we are developing adaptable topical delivery systems designed around the active ingredient, intended skin layer, disease mechanism, body site, population, release profile, and safety needs.
The objective is not simply maximum penetration. It is to support appropriate local delivery and retention, gradual release, formulation stability, and tolerability, with the aim of limiting unnecessary exposure.
Carrier characteristics may be adjusted to support flare, maintenance, or barrier-support needs. This advanced delivery work remains under development and is separate from our currently available products.
Helping people living with inflammatory skin conditions gain more clarity, more control, and better options over time.
Measure carefully. Build scientifically. Keep the individual at the center.
You help move the science forward
Every time you choose NellaDerm, you are doing more than using a product.
You are supporting continued research, validation, and development of a precision dermatology technology intended to go beyond general symptom management.
By choosing thoughtfully designed products today,
together we can continue advancing the science needed for more individualized care tomorrow.
Supporting a more personalized future in dermatology
By being part of NellaDerm, you are helping us build toward better options for people living with eczema and other chronic inflammatory skin conditions.
Our first focus is atopic dermatitis and broader eczema. After validation, the same technology may extend to other heterogeneous inflammatory skin diseases where biological variability also matters.
You are supporting an early-stage company led by scientists working to translate advanced algorithms, formulation science, and topical delivery into real-world care.